TM9SF4 and melanoma: Preliminary results clearly suggest that TM9SF4 is highly expressed on exosomes deriving from melanoma and ovary carcinoma patients, while TM9SF4 values in exosomes collected from healthy donors’ plasma are in the same range of background.